Similar Search Results

Pharmaceutical Pricing and Reimbursement Policies in Sweden

Moi͏̈se, Pierre - 2007

to low mark-ups in the distribution chain and no VAT for prescribed medicines, Sweden's public prices for pharmaceuticals … national income to pharmaceuticals. What limited evidence exists tends to suggest that relatively low pharmaceutical … reimbursement status of new pharmaceuticals and mandatory substitution of the lowest-cost generic alternative. The use of cost …

Persistent link: https://www.econbiz.de/10012447076

Coherence for Health : Innovation for New Medicines for Infectious Diseases

2009

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for...

Persistent link: https://www.econbiz.de/10012448189

Patient Knowledge and Antibiotic Abuse : Evidence from an Audit Study in China

Currie, Janet - 2010

We ask how patient knowledge of appropriate antibiotic usage affects both physicians prescribing behavior and the physician-patient relationship. We conduct an audit study in which a pair of simulated patients with identical flu-like complaints visits the same physician. Simulated patient A is...

Persistent link: https://www.econbiz.de/10012462056

Bundling Among Rivals : A Case of Pharmaceutical Cocktails

Lucarelli, Claudio - 2010

We empirically analyze the welfare effects of cross-firm bundling in the pharmaceutical industry. Physicians often treat patients with "cocktail" regimens that combine two or more drugs. Firms cannot price discriminate because each drug is produced by a different firm and a physician creates the...

Persistent link: https://www.econbiz.de/10012462336

Pricing and Reimbursement in U.S. Pharmaceutical Markets

Berndt, Ernst R. - 2010

branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …

Persistent link: https://www.econbiz.de/10012462361

Medicare Part D and the Financial Protection of the Elderly

Engelhardt, Gary V. - 2010

We examine the impact of the expansion of public prescription drug insurance coverage from Medicare Part D on the elderly and find evidence of substantial crowd-out. Using detailed data from the 2002-7 waves of the Medical Expenditure Panel Survey (MEPS), we estimate that the extension of Part D...

Persistent link: https://www.econbiz.de/10012462502

Medicare Part D and its Effect on the Use of Prescription Drugs, Use of Other Health Care Services and Health of the Elderly

Kaestner, Robert - 2010

We examine the effect of gaining prescription drug insurance as a result of Medicare Part D on use of prescription drugs, use of other medical services, and health for a nationally representative sample of Medicare beneficiaries. Given the heightened importance of prescription drugs for those...

Persistent link: https://www.econbiz.de/10012462642

The Impact of Direct-to-Consumer Advertising on Pharmaceutical Prices and Demand

Dave, Dhaval - 2010

Expenditures on prescription drugs are one of the fastest growing components of national health care spending, rising by almost three-fold between 1995 and 2007. Coinciding with this growth in prescription drug expenditures has been a rapid rise in direct-to-consumer advertising (DTCA), made...

Persistent link: https://www.econbiz.de/10012462683

Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures

Cook, Joseph P. - 2010

of about 0.090. While the magnitude of this elasticity is modest, as theory would predict--the effect of greater generic …

Persistent link: https://www.econbiz.de/10012462928

Does Prescription Drug Adherence Reduce Hospitalizations and Costs?

Encinosa, William - 2010

We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may...

Persistent link: https://www.econbiz.de/10012462961